FDA approval for Primary Screening on SurePath™

The cobas HPV Test is now the only HPV test approved for first-line screening with two common collection vials for Pap tests.

READ MORE

A new paradigm in the fight against cervical cancer

HPV primary screening algorithm
identifies more high grade disease than a
Pap test alone and maintains screening efficiency5.

THE CASE FOR PRIMARY SCREENING

Normal cytology doesn't always mean cancer free.

Up to one third of cervical cancers occur in screened women.2,3 Invasive cervical
cancer occurs in women with
normal Pap cytology.

LIMITATION OF PAP

1. SGO Press Release January 2015. 2. Leyden WA, Manos MM, Geiger AM, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005;97(9):675-683. 3. Andrae B, Kemetli L, Sparén P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.J Natl Cancer Inst. 2008;100(9):622-629. 4. ACOG Practice Bulletin 157; January 2016. 5.cobas HPV package insert.

Menu
Menu